09:56 AM EST - ProMIS Neurosciences, Inc. : Reported that a total of 6,289,851 of the common share purchase warrants issued on February 10 and February 21, 2017 in a non-brokered private placement were exercised at a price of $0.20 per share for gross proceeds of $1,257,970, the vast majority of such proceeds having been received in the last month prior to the February 21, 2020 expiry date. ProMIS Neurosciences, Inc.
shares T.PMN are trading unchanged at $0.21.
